Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
19,380,482
-
Shares change
-
-1,959,628
-
Total reported value, excl. options
-
$16,800,163
-
Value change
-
-$1,649,339
-
Put/Call ratio
-
124%
-
Number of buys
-
20
-
Number of sells
-
-49
-
Price
-
$0.8670
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q3 2025
95 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q3 2025.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,380,482 shares
of 129,337,627 outstanding shares and own 15% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6,078,844 shares), AMERIPRISE FINANCIAL INC (2,951,505 shares), BlackRock, Inc. (1,997,627 shares), MILLENNIUM MANAGEMENT LLC (1,668,648 shares), RENAISSANCE TECHNOLOGIES LLC (1,548,663 shares), GEODE CAPITAL MANAGEMENT, LLC (1,362,282 shares), STATE STREET CORP (454,495 shares), GSA CAPITAL PARTNERS LLP (310,754 shares), NORTHERN TRUST CORP (263,377 shares), and CITADEL ADVISORS LLC (263,369 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.